Figure 1.
Flowchart of the patient selection process. HCC, hepatocellular carcinoma; BCLC, Barcelona Clinic Liver Cancer; T+L+C, transarterial chemoembolization combined with lenvatinib plus camrelizumab; T+C, transarterial chemoembolization combined with camrelizumab; TACE, transarterial chemoembolization.